Catalyst Wire Dossier Catalyst Wire Dossier

Gelsectan

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Gelsectan, covering 2024-02-28 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome [NA]

See pricing